Answers are grounded in this paper and cite their sources.
Conceptual framework reveals multi-organ clearance impairment drives chronic disease progression, highlighting the thoracic duct as a critical anatomical bottleneck.
The Clearance Hypothesis proposes that impaired clearance capacity — not merely genetic predisposition or isolated organ dysfunction — is a primary driver of chronic disease progression. This document presents a comprehensive master synthesis mapping eight core clearance systems (hepatic, renal, lymphatic, microbiome, pulmonary, nervous, digestive, and cardiovascular) as a structurally unified network with shared vascular, lymphatic, and neural pathways converging at the thoracic duct — the body's single point of failure. An accessory clearance system (integumentary) and an interactive system (musculoskeletal) are also delineated. The synthesis identifies three stress effectors (cortisol, catecholamines, angiotensin II) that simultaneously degrade clearance infrastructure across all systems, creating self-reinforcing feedback loops. It establishes that standard laboratory values are lagging indicators, with organs maintaining compensatory function until 70–80% of reserve is lost, and proposes six rules for lab interpretation emphasizing trend tracking over binary thresholds. A five-stage intervention protocol (Steps 0–4) is presented, prioritizing clearance infrastructure support before targeted therapy using a whole-food-first philosophy with Eastern Woodlands botanicals. Clinical case patterns illustrate application across conditions including estrogen dominance, post-viral syndrome, metabolic syndrome, and early cognitive decline.
No takes yet. Share an insight, caveat, or question.
Veda Ariadne Hope McCoy (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: